🏆 Finalist — NIH Data Sharing Index (“S-Index”) Challenge

Jeffrey S. Dome

Children's National

ORCID: 0000-0002-9037-369X
Biochemistry, Genetics and Molecular BiologyMedicine

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 4%percentile
0.661Author DataRank

Indexed papers

2in pilot corpus
datarank_citation_only_1hop_v6· scope data_onlyMethodology
Why this DataRank?

An author's DataRank is the sum of the DataRanks of all 2 indexed papers attributed to them. A prolific author with many moderate-impact papers can outrank one with a single high-impact paper.

Author scores recompute whenever paper DataRanks are refreshed, so this number lags the underlying paper scores by at most one batch run.

Read the full methodology →

Top data-sharing exemplar

The highest-impact dataset this researcher has shared, ranked by DataRank — the single contribution doing the most to lift their data-sharing standing.

Rhabdoid Tumor of the Kidney and Soft Tissues: Results from National Wilms Tumor Study‐5 and Children's Oncology Group Study AREN0321

Pediatric Blood & Cancer(2024)10.1002/pbc.31490
Top 44%
0.420DataRank
Top 44%9 citations

Lindsay A. Renfro, Paul E. Grundy, Elizabeth J. Perlman, John A. Kalapurakal, Peter F. Ehrlich +15 more

Papers

Driven by 25 papers — median percentile 47. Top paper: “Outcome analysis of stage I epithelial‐predominant favorable‐histology Wilms tumors: A report from Children's Oncology Group study AREN03B2”.

Outcome analysis of stage I epithelial‐predominant favorable‐histology Wilms tumors: A report from Children's Oncology Group study AREN03B2

Cancer(2020)10.1002/cncr.32855
N/A
1.0DataRank · unranked
30 citations

Elizabeth A. Mullen, James I. Geller, Yueh‐Yun Chi, Geetika Khanna, Richard D. Glick +7 more

Genetic and epigenetic features of bilateral Wilms tumor predisposition in patients from the Children’s Oncology Group AREN18B5-Q

Nature Communications(2023)10.1038/s41467-023-43730-0
N/A
0.778DataRank · unranked
31 citations

Changde Cheng, Justin Williams, Timothy I. Shaw, Emília M. Pinto, Karissa M. Dieseldorff Jones +29 more

Outcome of donor-derived TAA-T cell therapy in patients with high-risk or relapsed acute leukemia post allogeneic BMT

Blood Advances(2022)10.1182/bloodadvances.2021006831
N/A
0.776DataRank · unranked
40 citations

Kenneth R. Cooke, Melanie Grant, Maja Stanojević, Carolina Colli Cruz, Michael D. Keller +20 more

Results of Treatment for Patients With Multicentric or Bilaterally Predisposed Unilateral Wilms Tumor (AREN0534): A report from the Children's Oncology Group

Cancer(2020)10.1002/cncr.32958
N/A
0.644DataRank · unranked
72 citations

Yueh‐Yun Chi, Murali Chintagumpala, Fredric A. Hoffer, Elizabeth J. Perlman, John A. Kalapurakal +14 more

Treatment of children with favorable histology Wilms tumor with extrapulmonary metastases: A report from the COG studies AREN0533 and AREN03B2 and NWTSG study NWTS‐5

Cancer(2023)10.1002/cncr.35099
N/A
0.567DataRank · unranked
21 citations

Carly R. Varela, Lindsay A. Renfro, Brett Tornwall, David Dix, Peter F. Ehrlich +13 more

Phase 1 study of sorafenib and irinotecan in pediatric patients with relapsed or refractory solid tumors

Pediatric Blood & Cancer(2021)10.1002/pbc.29282
N/A
0.461DataRank · unranked
10 citations

Brigitte C. Widemann, Pamela S. Hinds, Rochelle Bagatell, Suzanne Shusterman, Emily Stern +12 more

Rhabdoid Tumor of the Kidney and Soft Tissues: Results from National Wilms Tumor Study‐5 and Children's Oncology Group Study AREN0321

Pediatric Blood & Cancer(2024)10.1002/pbc.31490
Top 44%
0.420DataRank
Top 44%9 citations

Lindsay A. Renfro, Paul E. Grundy, Elizabeth J. Perlman, John A. Kalapurakal, Peter F. Ehrlich +15 more

Treatment and outcomes of clear cell sarcoma of the kidney: A report from the Children's Oncology Group studies AREN0321 and AREN03B2

Cancer(2024)10.1002/cncr.35266
N/A
0.402DataRank · unranked
12 citations

Lindsay A. Renfro, Ian Tfirn, Najat C. Daw, John A. Kalapurakal, Peter F. Ehrlich +12 more

Race and Ethnic Group Enrollment and Outcomes for Wilms Tumor: Analysis of the Current Era Children’s Oncology Group Study, AREN03B2

Journal of the American College of Surgeons(2024)10.1097/xcs.0000000000000999
Top 61%
0.241DataRank
Top 61%4 citations

Lindsay A. Renfro, Daniel J. Benedetti, Meera Kotagal, Hannah M. Phelps, Peter F. Ehrlich +13 more

The Genetic and Epigenetic Features of Bilateral Wilms Tumor Predisposition: A Report from the Children's Oncology Group AREN18B5-Q Study

Research Square(2023)10.21203/rs.3.rs-2675436/v1
N/A
0.165DataRank · unranked
2 citations

Changde Cheng, Justin Williams, Timothy I. Shaw, Emília M. Pinto, Karissa Dieseldorff-Jones +29 more

Long‐term outcomes and patterns of relapse in patients with bilateral Wilms tumor or bilaterally predisposed unilateral Wilms tumor, a report from the COG AREN0534 study

International Journal of Cancer(2024)10.1002/ijc.35080
N/A
0DataRank · unranked
10 citations

Jack Brzezinski, Lindsay A. Renfro, Brett Tornwall, Marcus M. Malek, Daniel J. Benedetti +15 more

Bilateral Wilms tumor with anaplasia: A report from the Children's Oncology Group Study AREN0534

Pediatric Blood & Cancer(2024)10.1002/pbc.30981
N/A
0DataRank · unranked
7 citations

Jennifer H. Aldrink, Lindsay A. Renfro, Elizabeth A. Mullen, Andrew J. Murphy, Jack Brzezinski +16 more

Updated favourable-histology Wilms tumour risk stratification: rationale for future Children’s Oncology Group clinical trials

Nature Reviews Urology(2025)10.1038/s41585-025-01055-1
N/A
0DataRank · unranked
13 citations

Nicholas G. Cost, Peter F. Ehrlich, Nicholas F. Evageliou, Elizabeth Fialkowski, Lauren Parsons +13 more

Treatment of focal anaplastic Wilms tumor: A report from the Children's Oncology Group AREN0321 and AREN03B2 studies

Cancer(2025)10.1002/cncr.35713
N/A
0DataRank · unranked
7 citations

Najat C. Daw, Lindsay A. Renfro, James I. Geller, John A. Kalapurakal, Geetika Khanna +10 more

Associations of Patient Age, Tumor Nephrectomy Weight, and Tumor Diameter with Event-Free and Overall Survival in Stage I or II Favorable Histology Wilms Tumor

Annals of Surgery(2025)10.1097/sla.0000000000006726
N/A
0DataRank · unranked
3 citations

Kelly Vallance, Ian Tfirn, Nicholas F. Evageliou, Daniel J. Benedetti, Robert C. Shamberger +15 more

AREN1721, a randomized phase 2 trial of axitinib+nivolumab combination therapy vs. single agent nivolumab for the treatment of TFE/translocation renal cell carcinoma (tRCC) across all age groups, an NCI National Clinical Trials Network (NCTN) phase 2 study.

Journal of Clinical Oncology(2025)10.1200/jco.2025.43.16_suppl.4521
N/A
0DataRank · unranked
7 citations

Lindsay A. Renfro, Matthew R. Zibelman, Ana M. Molina, Mamta Parikh, Luke Pater +8 more

Reopening Schools Safely: The Case for Collaboration, Constructive Disruption of Pre-Coronavirus 2019 Expectations, and Creative Solutions

The Journal of Pediatrics(2020)10.1016/j.jpeds.2020.05.022
N/A
0DataRank · unranked
22 citations

Lisa M. Guay‐Woodford, Bruce R. Blazar, Scott R. Bowman, Carrie L. Byington, Jeffrey S. Dome +12 more

A prospective study of pediatric and adolescent renal cell carcinoma: A report from the Children's Oncology Group AREN0321 study

Cancer(2020)10.1002/cncr.33173
N/A
0DataRank · unranked
26 citations

Nicholas G. Cost, Yueh‐Yun Chi, Brett Tornwall, Mariana M. Cajaiba, Elizabeth J. Perlman +9 more

Impact of the First Generation of Children’s Oncology Group Clinical Trials on Clinical Practice for Wilms Tumor

Journal of the National Comprehensive Cancer Network(2021)10.6004/jnccn.2021.7070
N/A
0DataRank · unranked
49 citations

Elizabeth A. Mullen, David Dix, Eric J. Gratias, Peter F. Ehrlich, Najat C. Daw +9 more

Pharmacogenetic and Clinical Predictors of Ondansetron Failure in a Diverse Pediatric Oncology Population

Research Square(2021)10.21203/rs.3.rs-762220/v1
N/A
0DataRank · unranked
0 citations

Jeffrey S. Dome, Jiaxiang Gai, Andrea M. Gross, Elena Postell, Pamela S. Hinds +4 more

Outcomes based on histopathologic response to preoperative chemotherapy in children with bilateral Wilms tumor: A prospective study (COG AREN0534)

Cancer(2022)10.1002/cncr.34219
N/A
0DataRank · unranked
17 citations

Elizabeth J. Perlman, Brett Tornwall, Yueh‐Yun Chi, Yeonil Kim, Fredric A. Hoffer +16 more

Pharmacogenetic and clinical predictors of ondansetron failure in a diverse pediatric oncology population

Supportive Care in Cancer(2022)10.1007/s00520-022-06818-9
N/A
0DataRank · unranked
7 citations

Jeffrey S. Dome, Jiaxiang Gai, Andrea M. Gross, Elena Postell, Pamela S. Hinds +4 more

Prognostic impact of lymph node involvement and loss of heterozygosity of 1p or 16q in stage III favorable histology Wilms tumor: A report from Children’s Oncology Group Studies AREN03B2 and AREN0532

Cancer(2023)10.1002/cncr.35084
N/A
0DataRank · unranked
11 citations

Lindsay A. Renfro, James I. Geller, Elizabeth J. Perlman, John A. Kalapurakal, Arnold C. Paulino +11 more

Advances in the clinical management of high‐risk Wilms tumors

Pediatric Blood & Cancer(2023)10.1002/pbc.30342
N/A
0DataRank · unranked
16 citations

Christa Koenig, Amy E. Armstrong, Jesper Brok, Beatriz de Camargo, Annelies M. C. Mavinkurve‐Groothuis +6 more

Data from Predicting Relapse in Favorable Histology Wilms Tumor Using Gene Expression Analysis: A Report from the Renal Tumor Committee of the Children's Oncology Group

(2023)10.1158/1078-0432.c.6517441
N/A
0DataRank · unranked
0 citations

Samantha Gadd, Norman E. Breslow, Colleen Cutcliffe, Simone Treiger Sredni, Irene Helenowski +6 more